Baxter Ventures identifies companies with promising technologies, products and/or therapies, and provides them with the capital and expertise needed to drive successful innovation. Baxter Ventures was created in 2011 by Baxter International Inc., which has an 80-year legacy of healthcare innovation and saving and sustaining lives worldwide.
Baxter Ventures invests in companies with innovative technologies, products and therapies with the ability to improve patient care globally and maximize value for investors and entrepreneurs. Our focus includes therapeutic areas complementary to those of Baxter's Medical Products and BioScience businesses, as well as cutting-edge technologies and therapies outside of our current product portfolio that have sustainable long-term growth potential.
As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to develop products and therapies that advance patient care worldwide. Areas of interest include:
- Acute and Intensive Care Pharmaceuticals
- Clinical Nutrition
- Critical Care
- Fluid Management Systems
- Hematologic Malignancies
- Home Care Therapies
- Infusion Systems/IV Tubing
- Pharmaceuticals/Solutions/Drug Delivery
- Rare/Orphan Diseases
- Regenerative Medicine
- Renal/Dialysis Drugs and Devices